BMY Bristol Myers Squibb

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.

$63.86  +1.62 (2.60%)
As of 01/27/2022 16:00:02 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/09/2001
Outstanding shares:  2,219,644,935
Average volume:  11,757,181
Market cap:   $138,639,022,640
Current dividend yield:  3.18%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2126335

---

Valuation   (See tab for details)

---

PE ratio:   -25.56
PB ratio:   3.71
PS ratio:   3.05
Return on equity:   -14.52%
Net income %:   -11.89%